Anmeldung erfolgt in Kürze...
Details werden geladen...
Regulator mandates full review of globally unapproved drugs - The Economic Times
Indias drug regulator has clarified that new drugs not approved anywhere globally must undergo the full domestic regulatory process, even if Indian patients participated in global clinical trials. CDSCO said such applications require comprehensive safety and efficacy evaluation under existing rules.
Ähnliche Seiten
IPA seeks to regularise 'legacy' drugs - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-alliance-pushes-for-regularization-of-unapproved-legacy-drugs-in-india/articleshow/132871282.cmsRegulator flags unauthorised mfg & sale of male infertility drug - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/regulator-flags-unauthorised-mfg-sale-of-male-infertility-drug/articleshow/133164721.cmsGovt plans new drugs law to overhaul pharma, medical device regulation - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/govt-plans-new-drugs-law-to-overhaul-pharma-medical-device-regulation/articleshow/133015180.cmsAstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazenecas-enhertu-gets-regulatory-approval-in-india-for-first-line-her2-positive-breast-cancer/articleshow/131650857.cmsGovt steps up efforts to curb 'irrational' drugs with crackdown on FDCs not part of official database - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/govt-steps-up-efforts-to-curb-irrational-drugs-with-crackdown-on-fdcs-not-part-of-official-database/articleshow/132271985.cms